Fosfomycin trometamol is a broad-spectrum antibiotic used to treat uncomplicated urinary tract infections (UTIs). It is the trometamol (or tromethamine) salt of fosfomycin, which is a phosphonic acid derivative. Fosfomycin trometamol is known for its unique mechanism of action and its effectiveness against a variety of bacterial pathogens.
Fosfomycin trometamol is primarily used for:
It is often used as a single-dose treatment for acute cystitis in women.
| Brand Name | Novefos |
|---|---|
| Type | Oral Powder |
| Weight | 3 gm/sachet |
| Generic | Fosfomycin Trometamol |
| Manufacturer | Nuvista Pharma Ltd. |
| Available in | English বাংলা |
Fosfomycin trometamol works by inhibiting bacterial cell wall synthesis. It irreversibly binds to and inhibits the enzyme enolpyruvate transferase, which is crucial for the biosynthesis of peptidoglycan in bacterial cell walls. This action disrupts cell wall construction, leading to bacterial cell death.
Fosfomycin trometamol typically begins to work within a few hours of administration. Most patients start to feel symptomatic relief within 2 to 3 days. The full course of treatment is usually effective in clearing the infection within a week, but symptomatic improvement can be noticed sooner.
Fosfomycin trometamol is well absorbed from the gastrointestinal tract. After oral administration, it achieves peak plasma concentrations within 2 to 4 hours. Its absorption is not significantly affected by food.
Fosfomycin trometamol is excreted primarily via the kidneys. About 90% of the drug is eliminated unchanged in the urine. A small amount is excreted in the feces.
The typical dosage for fosfomycin trometamol for the treatment of uncomplicated UTIs is:
For certain patients, additional dosing or adjustment might be required based on specific clinical conditions and individual patient needs. Always follow the prescribing information provided by a healthcare provider.
Fosfomycin trometamol is administered orally. It is typically available as a powder that should be dissolved in water before ingestion. The solution should be consumed immediately after preparation.
Common side effects of fosfomycin trometamol include:
Serious side effects are rare but may include:
Acute toxicity from fosfomycin trometamol is uncommon. In the event of overdose, symptoms may include gastrointestinal distress and renal impairment. Treatment generally involves supportive care and monitoring. Seek medical attention if an overdose is suspected.
Precautions include:
Fosfomycin trometamol may interact with other medications, including:
Consult a healthcare provider to discuss potential drug interactions.
There are no significant food interactions with fosfomycin trometamol. It can be taken with or without food. However, it should be taken with a full glass of water.
Use with caution in individuals with:
Fosfomycin trometamol is classified as Category B for pregnancy, indicating that there is no evidence of harm to the fetus in animal studies, but there are no well-controlled studies in pregnant women. It should be used during pregnancy only if clearly needed.
Fosfomycin trometamol is excreted in breast milk in small amounts. It is generally considered safe for use during lactation, but it is advised to consult a healthcare provider before using it while breastfeeding.
Acute overdose may cause gastrointestinal symptoms such as nausea, vomiting, and diarrhea. Supportive treatment and hydration are typically required. Seek medical attention if an overdose is suspected.
Fosfomycin trometamol is contraindicated in individuals with:
Follow the prescribed dosage and administration instructions carefully. Dissolve the powder in water as directed and consume the solution immediately. Do not exceed the recommended dose or duration of treatment without consulting a healthcare provider.
Store fosfomycin trometamol at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children.
The volume of distribution of fosfomycin trometamol is approximately 0.3 L/kg, indicating that it distributes throughout the body but predominantly remains in the urine.
The half-life of fosfomycin trometamol is approximately 4 to 6 hours, supporting its dosing schedule as a single-dose treatment.
Fosfomycin trometamol is primarily cleared by the kidneys. The clearance rate can be affected by renal function, and dose adjustments may be necessary for patients with impaired renal function.
See in details version Novefos Oral Powder 3 gm/sachet also Novefos Oral Powder 3 gm/sachet in bangla
Dr. A.S.M. Shafiul Azam Tuhin
Urology (Kidney Ureter, Bladder, Prostate) Specialist & Surgeon